News
Droplet digital polymerase chain reaction (ddPCR) technology is emerging as an efficient, accurate, and precise way to measure transgene copy numbers. With it, scientists may screen for clonal ...
Hosted on MSN2mon
Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms
Bio-Rad Laboratories BIO recently announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include the company's QX Continuum ddPCR system, along with ...
insights from industryDr Chelsea PrattBiopharma Segment Marketing ManagerBio-Rad Laboratories In this interview, NewsMedical speaks to Dr Chelsea Pratt about Accurately quantifying AAV capsids ...
Lakkaraju stated that Bio-Rad is raising its 2025 full-year guide to reflect Q2 results, the Stilla acquisition, and evolving market conditions. The company now expects total currency-neutral revenue ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback